Canada Grants Cereboost Ginseng Cognitive Claims
The health claims apply to Cereboost when included at a 200 mg daily dose.
Health Canada has approved Cereboost, an American ginseng ingredient from Naturex (Avignon, France), for cognitive health claims as well as a natural product number (NPN) indicating Health Canada reviewed the ingredient for safety and efficacy.
Cereboost, when included at a 200 mg daily dose, can now tout the following health claims in the Canadian market: 1) helps support cognitive function, 2) helps support cognitive performance, and 3) helps support working memory.
“Our clients will gain multiple benefits from this recognition [by Health Canada],” said Maxence Duprez, sales director for Canada, in a Naturex press release. “They can register their finished products in a shorter period of time and drastically reduce the time-to-market of their launches.”
Read more about current and upcoming regulatory changes in Canada.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
